Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 526 to 536 of 536 results for physical activity

  1. NICE recommended weight-loss drug to be made available in specialist NHS services

    Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service.

  2. Tirzepatide - a new chapter in obesity treatment

    Dr Patterson, a GP working on the frontline of primary care, describes why he is encouraged by NICE's approval of tirzepatide (Mounjaro).

  3. Digital services to enable easier access to weight management support

    Four digital programmes can be used to help the NHS deliver specialist weight management services to support the use of medication in England

  4. Consultation on NHS England proposals for a phased launch of obesity injection

    Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.

  5. NICE recommended a new gene therapy, transformative cystic fibrosis medicines and an obesity jab, during election period

    More than 20 pieces of draft and final guidance on a range of medicines and medical conditions were published during the pre-election period.

  6. NICE recommends new drug for people living with obesity

    Thousands of people living with obesity are set to benefit from a new drug which has helped those using it to reduce their weight by more than 10 per cent.

  7. First treatment to target heart condition set to benefit

    NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.

  8. Seven technologies recommended to help people with non-specific low back pain

    People with non-specific low back pain could be offered apps to help them manage their condition after seven digital technologies were recommended in draft guidance.

  9. NICE guidance addresses the best approach to the diagnosis and management of ME/CFS

    NICE has today (10 November 2020) published its draft guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  10. New treatment option for adults with obesity and non-diabetic hyperglycaemia

    All eligibility criteria must be met for Liraglutide to be offered.

  11. NICE conditionally recommends 5 promising technologies for Parkinson's disease

    These promising technologies could help improve symptoms and quality of life for people with Parkinson’s disease.